Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.9B | 14.6B | 13.8B | 14.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 6.3B | -17.3B | 6.2B | 6.5B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 7.6B | 8.0B | 7.9B | 7.8B |
| Tax provision | 1.8B | 2.0B | 1.8B | 1.9B |
| Net income | 5.8B | 6.0B | 6.2B | 5.8B |
| Basic EPS | — | — | 7.2 | 6.8 |
| Diluted EPS | — | — | 7.2 | 6.8 |
| Basic average shares | — | — | 856.3M | 858.7M |
| Diluted average shares | — | — | 856.3M | 858.7M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 7.6B | 8.0B | 7.9B | 7.8B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |